GSK gets CDSCO Panel nod to market anticancer Niraparib Tablet Susmita Roy12 Oct 2022 6:00 PM ISTNew Delhi: Granting the proposal of a local clinical trial waiver, the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Phase II trial of Jemperli (dostarlimab) plus chemotherapy in patients with metastatic non-squamous non-small cell lung cancer shows positive headline results: GSK Ruchika Sharma9 Oct 2022 2:00 PM ISTJemperli is a programmed death receptor-1 (PD-1)-blocking antibody that binds to the PD-1 receptor and blocks its interaction with the PD-1 ligands...
USFDA expands use of GSK Boostrix vaccine during pregnancy to prevent whooping cough in infants Ruchika Sharma8 Oct 2022 11:16 AM ISTUS: The U.S. Food and Drug Administration (USFDA) has allowed the use of GlaxoSmithKline's Boostrix vaccine during the third trimester of...
GSK, Spero Therapeutics ink pact for complicated urinary tract infections antibiotic Tebipenem pivoxil hydrobromide Ruchika Sharma25 Sept 2022 1:13 PM ISTGSK will receive an exclusive licence to develop and commercialise tebipenem pivoxil HBr in all countries except Japan and certain other Asian...
GSK announces USFDA committee to review Zejula overall survival data from NOVA phase III trial in recurrent ovarian cancer Ruchika Sharma24 Sept 2022 5:41 PM ISTUK: GSK plc has announced that the US Food and Drug Administration (USFDA) will convene a meeting of the Oncologic Drugs Advisory Committee (ODAC) to...
COVID-19 Treatment: GSK Sotrovimab, Roche antibody cocktail casirivimab-imdevimab no longer recommended by WHO Ruchika Sharma22 Sept 2022 4:14 PM ISTBoth therapies continue to be recommended for use by the European drugs regulator.
Haleon believes it is not liable for any potential Zantac liabilities Ruchika Sharma20 Sept 2022 3:30 PM ISTHaleon has repeatedly said that it never marketed Zantac in any form in the United States, either as Haleon or as GSK Consumer Healthcare.
GSK notice to Akums, associate on alleged trademark infringement on its Ranitidine brand Zinetac Farhat Nasim8 Sept 2022 6:23 PM ISTNew Delhi: Locking horns over alleged trademark infringement of 'Zinetac', Glaxo Smith Kline (GSK) Pharmaceuticals has issued cease and desist notices...
WHO prequalifies GSK malaria vaccine Mosquirix Ruchika Sharma8 Sept 2022 2:03 PM ISTWorking in collaboration with PATH and other partners, GSK developed Mosquirix, the first vaccine to help protect children against the deadliest form...
Indian Pharma Market sees 12.1 percent growth in August: AIOCD-AWACS Report Farhat Nasim7 Sept 2022 5:53 PM ISTNew Delhi: The Indian Pharmaceutical Market (IPM) saw significant growth of 12.1 percent in value and 4.8 percent in volume, in the month of August,...
GSK, Sanofi see EU drugs regulator decision on COVID booster in weeks Ruchika Sharma6 Sept 2022 2:00 PM ISTThe vaccine could be used as a booster for people who had received any other COVID-19 vaccine, Triomphe said.
GSK new drug application for Myelofibrosis treatment Momelotinib accepted by USFDA Ruchika Sharma19 Aug 2022 2:00 PM ISTNew Delhi: GSK plc has announced that the US Food and Drug Administration (USFDA) has accepted the New Drug Application (NDA) for momelotinib, a...
